
This collection of facts given below is not a medical advice by a doctor. So if you are going to get a Herpes Zoster Vaccine in near future then it better to consult your doctor regarding this thing.
Shingrix versus Zostavax
Zostavax
|
Shingrix
| |
Manufacturer | Merck | GlaxoSmithKline (GSK) |
Releasing Date | 2006 | Expected in 2017 |
Trial Results | Reduced appearance of Shingles by 70% in 50-59 Years Age Group, 64% in 60-69 Years, and 38% in above 70 Years. | 97% protection in all age group above 50 Years. |
Vaccination Age | CDC suggests that this vaccine should be taken after attaining the age of 60 Years | According to GSK you may take this vaccine after 50 Years of age. |
Dosage | Its a single dose vaccine given in one shot | This vaccine is given in two doses with an interval of 2 to 6 months. |
How does it work | Live attenuated virus of chicken pox is used in this vaccine to make our immune system create antibodies to fight against Herpes Zoster. | It uses only the antigens in the virus that stimulate the immune system. |
Booster Dose | There is no booster dose of Zostavax. The effect of this vaccine fades away with time and does not provide any protection after 8 years. However some studies have shown that booster dose of Zostavax is safe for people over 70 years of age, only if they were not vaccinated in past 10 years. | Studies are going on to find if people vaccinated with Zostavax or Shingrix can get a booster dose of Shingrix or not. It will take some time for these studies to conclude as it is a new vaccine. |
Post a Comment
Post a Comment